Endocrinopathic laminitis in the horse

Clinical Techniques in Equine Practice

Volumn 3, Issue 1, 2004, Pages 45-56

  Johnson, Philip J ^a   Messer, Nat T ^a   Slight, Simon H ^a   Wiedmeyer, Charles ^a   Buff, Preston ^a   Ganjam, Venkataseshu K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

chronic laminitis; cortisol; Cushing's disease; glucocorticoid 11 hydroxysteroid dehydrogenase; insulin resistance; metabolic syndrome; obesity; pituitary pars intermedia dysfunction; pituitary pars intermedia derived pro opiomelanocortin (POMC)

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CATECHOLAMINE; GLUCOCORTICOID; HYDROCORTISONE; PEPTIDE DERIVATIVE; PROOPIOMELANOCORTIN; STEROID;

ANIMAL DISEASE; ATHEROSCLEROSIS; DISEASE PREDISPOSITION; ENDOCRINE DISEASE; GLUCOSE TRANSPORT; GLYCEMIC INDEX; HOOF AND CLAW; HORSE; HYPERADRENOCORTICISM; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOPHYSIS INTERMEDIATE LOBE; INSULIN RESISTANCE; LAMINITIS; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE; VASCULAR SMOOTH MUSCLE; VETERINARY MEDICINE;

EQUIDAE; EQUUS CABALLUS;

EID: 10944232507     PISSN: 15347516     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ctep.2004.07.004     Document Type: Article

References (104)

1. S.R. Bailey, C.M. Marr, J. Elliott Current research and theories on the pathogenesis of acute laminitis in the horse Vet J 167 2004 129 142
2. C.C. Pollitt, M. Kyaw-Tanner, K.R. French Equine laminitis Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners 2003 New Orleans, LA, pp. 103-115
3. H.E. Garner, J.R. Coffman, A.W. Hahn Equine laminitis of alimentary origin An experimental model Am J Vet Res 36 1975 441 444
4. P.D. Minnick, C.M. Brown, W.E. Braselton The induction of equine laminitis with an aqueous extract of the heartwood of black walnut (Juglans nigra) Vet Hum Toxicol 29 1987 230 233
5. R.F. Sprouse, H.E. Garner, E.M. Green Plasma endotoxin levels in horses subjected to carbohydrate induced laminitis Equine Vet J 19 1987 25 28
6. B.A. Mungall, C.C. Pollitt Thermolysin activates equine lamellar hoof matrix metalloproteinases J Comp Pathol 126 2002 9 16
7. B.A. Mungall, M. Kyaw-Tanner, C.C. Pollitt In vitro evidence for a bacterial pathogenesis of equine laminitis Vet Microbiol 79 2001 209 223
8. S.R. Bailey, L.M. Katz, Y. Berhane Seasonal changes in plasma concentrations of cecum-derived amines in clinically normal ponies and ponies predisposed to laminitis Am J Vet Res 64 2003 1132 1138
9. J. Elliott, Y. Berhane, S.R. Bailey Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets Am J Vet Res 64 2003 1124 1131
10. P.J. Johnson, S.C. Tyagi, L.C. Katwa Activation of extracellular matrix metalloproteinases in equine laminitis Vet Rec 142 1998 392 396
11. D.J. Weiss, O.A. Evanson, D. McClenahan Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis Am J Vet Res 58 1997 1376 1380
12. D.J. Weiss, O.A. Evanson, D. McClenahan Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies Am J Vet Res 59 1998 814 817
13. G.L. Fontaine, J.K. Belknap, D. Allen Expression of interleukin-1β in the digital laminae of horses in the prodromal stage of experimentally induced laminitis Am J Vet Res 62 2001 714 720
14. L.C. Katwa, P.J. Johnson, V.K. Ganjam Expression of endothelin in equine laminitis Equine Vet J 31 1999 243 247
15. S.C. Eades, A.M.S. Holm, R.M. Moore A review of the pathophysiology and treatment of acute laminitis Pathophysiologic and therapeutic implications of endothelin-1 Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners 2002 Orlando, FL, pp. 353-361
16. D.H. Rodgerson, J.K. Belknap, J.N. Moore Investigation of mRNA expression of tumor necrosis factor-α, interleukin-1β, and cyclooxygenase-2 in cultured equine digital artery smooth muscle cells after exposure to endotoxin Am J Vet Res 62 2001 1957 1963
17. P.J. Johnson, J.M. Kreeger, M. Keeler Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis Equine Vet J 32 2000 462 468
18. C.C. Pollitt, M. Daradka Equine laminitis basement membrane pathology Loss of type IV collagen, type VII collagen and laminin immunostaining Equine Vet J Suppl (Sept.) 1998 139 144
19. R.J. Hunt A retrospective evaluation of laminitis in horses Equine Vet J 25 1993 61 64
20. B.W. Rohrbach, E.M. Green, J.W. Oliver Aggregate risk study of exposure to endophyte-infected (Acremonium coenophialum) tall fescue as a risk factor for laminitis in horses Am J Vet Res 56 1995 22 26
21. P.J. Johnson The equine metabolic syndrome (peripheral Cushing's syndrome) Vet Clin N Am Equine Pract 18 2002 271 293
22. P.J. Johnson, S.H. Slight, V.K. Ganjam Glucocorticoids and laminitis in the horse Vet Clin N Am Equine Pract 18 2002 219 236
23. H.C. Schott Pituitary pars intermedia dysfunction Equine Cushing's disease Vet Clin N Am Equine Pract 18 2002 237 270
24. P. Eyre, P.J. Elmes, S. Strickland Corticosteroid-potentiated vascular responses of the equine digit A possible pharmacologic basis for laminitis Am J Vet Res 40 1979 135 138
25. D.M. Hood, D.A. Grosenbaugh, M.R. Slater Vascular perfusion in horses with chronic laminitis Equine Vet J 26 1994 191 196
26. F.D. Galey, A.R. Twardock, T.E. Goetz Gamma scintigraphic analysis of the distribution of perfusion of blood in the equine foot during black walnut (Juglans nigra)-induced laminitis Am J Vet Res 51 1990 688 695
27. N. Ackerman, H.E. Garner, J.R. Coffman Angiographic appearance of the normal equine foot and alterations in chronic laminitis J Am Vet Med Assoc 166 1975 58 62
28. H.S. Adair, D.O. Goble, J.L. Schmidhammer Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses Am J Vet Res 61 2000 862 868
29. K. French, C.C. Pollitt, M.A. Pass Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses J Vet Pharmacol Ther 23 2000 287 292
30. P.J. Johnson, V.K. Ganjam, S.H. Slight Tissue-specific dysregulation of cortisol metabolism in equine laminitis Equine Vet J 36 2004 41 45
31. D.S. Kronfeld Equine Syndrome X, the Metabolic Disease, and Equine Grain-associated Disorders Nomenclature and dietetics Journal of Equine Veterinary Science 23 2003 567 569
32. G. Reaven Metabolic syndrome Pathophysiology and implications for management of cardiovascular disease Circulation 106 2002 286 288
33. N. Frank, J. Sojka, N.T. Messer Equine thyroid dysfunction Vet Clin N Am Equine Pract 18 2002 305 319
34. C.M. Vischer, J.H. Foreman, P.D. Constable Hemodynamic effects of thyroidectomy in sedentary horses Am J Vet Res 60 1999 14 21
35. J.E. Lowe, B.H. Baldwin, R.H. Foote Equine hypothyroidism The long-term effects of thyroidectomy on metabolism and growth in mares and stallions Cornell Vet 64 1974 276 295
36. T.R. Boosinger, J.P. Brendemuehl, D.L. Bransby Prolonged gestation, decreased triiodothyronine concentration, and thyroid gland histomorphologic features in newborn foals of mares grazing Acremonium coenophialum-infected fescue Am J Vet Res 56 1995 66 69
37. B.A. Breuhaus Thyroid function in mature horses ingesting endophyte-infected fescue seed J Am Vet Med Assoc 223 2003 340 345
38. L.K. Abney, J.W. Oliver, C.R. Reinemeyer Vasoconstrictive effects of Tall Fescue alkaloids on equine vasculature J Equine Vet Sci 13 1993 334 340
39. H. Cushing The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) Bull Johns Hopkins Hosp 50 1932 137 195
40. J.H. van der Kolk, M.H. Mars, I. van der Gaag Adrenocortical carcinoma in a 12-year-old mare Vet Rec 134 1994 113 115
41. J.H. van der Kolk, J. Ijzer, P.A. Overgaauw Pituitary-independent Cushing's syndrome in a horse Equine Vet J 33 2001 110 112
42. A. Misra, N.K. Vikram Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots Nutrition 19 2003 457 466
43. G.N. Chaldakov, I.S. Stankulov, M. Hristova Adipobiology of disease Adipokines and adipokine-targeted pharmacology Curr Pharm Des 9 2003 1023 1031
44. D.L. Peroni, S. Stanley, C. Kollias-Baker Prednisone per os is likely to have limited efficacy in horses Equine Vet J 34 2002 283 287
45. P.J. Johnson, D.K. Bowles, N.T. Messer Dexamethasone alters equine digital artery smooth muscle ion channel activity and contractility Role in glucocorticoid-associated laminitis? J Vet Int Med 17 2003 457 458
46. C.C. Pollitt Basement membrane pathology A feature of acute equine laminitis Equine Vet J 28 1996 38 46
47. B.J. McCoy, R.F. Diegelmann, I.K. Cohen In vitro inhibition of cell growth, collagen biosynthesis and prolylhydroxylane activity by triamcinalone acetonide Proc Soc Exp Biol Med 153 1980 216 222
48. M.S. Bitar Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds Surgery 127 2000 687 695
49. M. Serres, J. Viac, D. Schmitt Glucocorticoid receptor localization in human epidermal cells Arch Dermatol Res 288 1996 140 146
50. M.P. Gras, F. Verrecchia, J. Uitto Downregulation of human type VII collagen (COL7A1) promoter activity by dexamethasone. Identification of a glucocorticoid receptor binding region Exp Dermatol 10 2001 28 34
51. K.A. Hendry, A.J. MacCallum, C.H. Knight Effect of endocrine and paracrine factors on protein synthesis and cell proliferation in bovine hoof tissue culture J Dairy Res 66 1999 23 33
52. M.A. Pass, S. Pollitt, C.C. Pollitt Decreased glucose metabolism causes separation of hoof lamellae in vitro A trigger for laminitis? Equine Vet J Suppl (Sept) 1998 133 138
53. W.F. Ganong Review of Medical Physiology Twentieth ed. 2001 McGraw-Hill New York pp. 322-343
54. N.M. Davies, M.R. Wright, F. Jamali Anti-inflammatory drug-induced small intestinal permeability The rat is a suitable model Pharm Res 11 1994 1652 1656
55. S. Kiziltas, N. Imeryuz, T. Gurcan Corticosteroid therapy augments gastroduodenal permeability to sucrose Am J Gastroenterol 93 1998 2420 2425
56. J.B. Meddings, M.G. Swain Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat Gastroenterology 119 2000 1019 1028
57. J.D. Soderholm, M.H. Perdue Stress and gastrointestinal tract. II. Stress and intestinal barrier function Am J Physiol Gastrointest Liver Physiol 280 2001 G7 G13
58. C.C. Pollitt, C.T. Davies Equine laminitis Its development coincides with increased sublamellar blood flow Equine Vet J Suppl (Sept) 1998 125 132
59. J.R. Seckl, N.M. Morton, K.E. Chapman Glucocorticoids and 11β-hydroxysteroid dehydrogenase in adipose tissue Recent Prog Horm Res 59 2004 359 393
60. W.A. Hsueh, R.E. Law Diabetes is a vascular disease J Investig Med 46 1998 387 390
61. F. Cosentino, T.F. Lusher Endothelial dysfunction in diabetes mellitus J Cardiovasc Pharmacol 32 suppl. 3 1998 S54 S61
62. J.R. Seckl, B.R. Walker Minireview: 11β-hydroxysteroid dehydrogenase type 1: A tissue-specific amplifier of glucocorticoid action Endocrinology 142 2001 1371 1376
63. E. Rask, T. Olsson, S. Soderberg Tissue specific dysregulation of cortisol metabolism in human obesity J Clin Endocrinol Metabol 86 2001 1418 1421
64. H. Masuzaki, J. Paterson, H. Shinyama A transgenic model of visceral obesity and the metabolic syndrome Science 294 2001 2166 2170
65. P.M. Stewart Tissue-specific Cushing's syndrome, 11β-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action Eur J Endocrinol 149 2003 163 168
66. P.J. Johnson, N.T. Messer, E. Kellon Treatment of equine metabolic syndrome Update on equine therapeutics Compend Contin Educ Pract Vet 26 2004 122 130
67. S.L. Ralston Insulin and glucose regulation Vet Clin N Am Equine Pract 18 2002 295 304
68. J.V. Neel Diabetes mellitus A "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14 1962 353 362
69. C.J. Lyon, R.E. Law, W.A. Hsueh Minireview Adiposity, inflammation, and atherogenesis Endocrinology 144 2003 2195 2200
70. S.L. Ralston, A. Black, L. Suslak-Brown Postprandial insulin resistance associated with osteochondrosis in weanling fillies J Anim Sci 76 suppl. 1 1998 176
71. I.J. Bujalaska, S. Kumar, P.M. Stewart Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349 1997 1210 1213
72. J.R. Field, L.B. Jeffcott Equine laminitis Another hypothesis for pathogenesis Med Hypotheses 30 1989 203 210
73. P. Alford, S. Geller, B. Richardson A multicenter, matched case-control study of risk factors for equine laminitis Prev Vet Med 49 2001 209 222
74. M. Ehrhart-Bornstein, V. Lamounier-Zepter, A. Schraven Human adipocytes secrete mineralocorticoid-releasing factors Proc Natl Acad Sci USA 100 2003 14211 14216
75. D.B. Corry, M.L. Tuck Selective aspects of the insulin resistance syndrome Curr Opin Nephrol Hypertens 10 2001 507 514
76. G. Boden Role of fatty acids in the pathogenesis of insulin resistance and NIDDM Diabetes 46 1997 3 10
77. J.W. Tomlinson, P.M. Stewart The functional consequences of 11β-hydroxysteroid dehydrogenase expression in adipose tissue Horm Metab Res 34 2002 746 751
78. J.R. Sowers, E.D. Frohlich Insulin and insulin resistance Impact on blood pressure and cardiovascular disease Med Clin North Am 88 2004 63 82
79. A.R. Saltiel, J.E. Pessin Insulin signaling in microdomains of the plasma membrane Traffic 4 2003 711 716
80. S.C. Benoit, D.J. Clegg, R.J. Seeley Insulin and leptin as adiposity signals Recent Prog Horm Res 59 2004 267 285
81. A.D. Baron Hemodynamic actions of insulin Am J Physiol 267 1994 E187 E202
82. N. Begum Insulin signaling in the vasculature Front Biosci 8 2003 s796 s804
83. L. Zhang, M.A. Vincent, S.M. Richards Insulin sensitivity of muscle capillary recruitment in vivo Diabetes 53 2004 447 453
84. V. Fonseca, C. Desouza, S. Asnani Nontraditional risk factors for cardiovascular disease in diabetes Endocrin Rev 25 2004 153 175
85. M.C. Garcia, J. Beech Equine intravenous glucose tolerance test Glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma Am J Vet Res 47 1986 570 572
86. K.E.P.M. Rijnen, J. van der Kolk Determination of reference range values indicative of glucose metabolism and insulin resistance by use of glucose clamp techniques in horses and ponies Am J Vet Res 64 2003 1260 1264
87. A.M. Suliman, R. Freaney, T.P. Smith The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency Clin Endocrinol (Oxf) 59 2003 380 387
88. D. Giugliano, A. Ceriello, G. Paolisso Oxidative stress and diabetic vascular complications Diabetes Care 19 1996 257 267
89. J.A. Nicollerat Elevated plasma glucose levels increase risk for complications Diabetes Educ 26 suppl. 2000 11 13
90. H.H. Ting, F.K. Timimi, K.S. Boles Vitamin C improves endothelium-dependent vasodilatation in patients with non-insulin-dependent diabetes mellitus J Clin Invest 97 1996 22 28
91. K.S. Rugh, H.E. Garner, R.F. Sprouse Left ventricular hypertrophy in chronically hypertensive ponies Lab Anim Sci 37 1987 335 338
92. I. Juhan-Vague, P.E. Morange, M.C. Alessi The insulin resistance syndrome Implications for thrombosis and cardiovascular disease Pathophysiol Haemost Thromb 32 2002 269 273
93. S. Uemura, H. Matsushita, W. Li Diabetes mellitus enhances vascular matrix metalloproteinase activity Role of oxidative stress Circ Res 88 2001 1291 1298
94. A. Orzechowski Justification for antioxidant preconditioning (or how to protect insulin-mediated actions under oxidative stress) J Biosci 28 2003 39 49
95. S.M. Grundy, H.B. Brewer, J.I. Cleeman Definition of metabolic syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
96. J.F. Freestone, R. Beadle, K. Shoemaker Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake Equine Vet J 24 1992 187 190
97. K.A. Watts Soaking hay to remove excess soluble carbohydrate (abstr) Proceedings of the 2nd Annual International Equine Conference On Laminitis and Diseases of the Foot 2003 Palm Beach, FL
98. K.A. Watts, N.J. Chatterton A review of factors affecting carbohydrate levels in forage J Equine Vet Sci 24 2004 84 86
99. N.O. Dybdal, K.M. Hargreaves, J.E. Madigan Diagnostic testing for pituitary pars intermedia dysfunction in horses Am J Vet Res 204 1994 627 632
100. J.H. van der Kolk, T. Wensing, H.C. Kalsbeek Laboratory diagnosis of equine pituitary pars intermedia adenoma Domest Anim Endocrinol 12 1995 35 39
101. L. Couteil, M.R. Paradis, J. Knoll Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism J Vet Int Med 10 1996 1 6
102. M.T. Donaldson, B.H. LaMonte, P. Morresey Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease) J Vet Int Med 16 2002 742 746
103. D. McFarlane, M.T. Donaldson, T.M. Saleh The role of dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction (equine Cushing's disease) Proc Am Assoc Equine Pract 49 2003 233 237
104. D.R. Henneke, G.D. Potter, J.L. Kreider Relationship between condition score, physical measurements and body fat percentage in mares Equine Vet J 15 1983 371 372